Beyond PD-L1: Assessment of LAG-3 and other predictive biomarkers in non-small cell lung carcinoma

被引：0
|
作者：
Hung, Yin P. [1 ,2 ]
Mino-Kenudson, Mari [1 ,3 ,4 ]
机构：
[1] Harvard Med Sch, Pathol, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Anat & Mol Pathol, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Pulm & Gastrointestinal Pathol, Boston, MA 02114 USA
来源：
CANCER CYTOPATHOLOGY | 2023年 / 131卷 / 03期
关键词：
T-CELLS; CANCER; EXPRESSION; ASSOCIATION; MICROENVIRONMENT; IMMUNOTHERAPY; PEMBROLIZUMAB; TUMORS;
D O I：
10.1002/cncy.22640
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：151 / 153
页数：3
相关论文
共 50 条
  • [1] Biomarkers predictive of PD1/PD-L1 immunotheraphy in non-small cell lung cancer
    Lupo, A.
    Alifano, M.
    Wislez, M.
    Boulle, G.
    Velut, Y.
    Biton, J.
    Cremer, I.
    Goldwasser, F.
    Leroy, K.
    Damotte, D.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2018, 74 (05) : 339 - 350
  • [2] Challenges of PD-L1 testing in non-small cell lung cancer and beyond
    Wang, Minyu
    Wang, Sen
    Trapani, Joseph A.
    Neeson, Paul J.
    JOURNAL OF THORACIC DISEASE, 2020, 12 (08) : 4541 - 4548
  • [3] Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non-small cell lung cancer
    Shien, Kazuhiko
    Papadimitrakopoulou, Vassiliki A.
    Wistuba, Ignacio I.
    LUNG CANCER, 2016, 99 : 79 - 87
  • [4] Biomarkers of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Beyond PD-L1
    Cabezon-Gutierrez, Luis
    Custodio-Cabello, Sara
    Palka-Kotlowska, Magda
    Alonso-Viteri, Soledad
    Khosravi-Shahi, Parham
    CLINICAL LUNG CANCER, 2021, 22 (05) : 381 - 389
  • [5] PD-1 and PD-L1 as immunotherapy targets and biomarkers in non-small cell lung cancer
    Tsoukalas, Nikolaos
    Kiakou, Maria
    Tsapakidis, Konstantinos
    Tolia, Maria
    Aravantinou-Fatorou, Eleni
    Baxevanos, Panagiotis
    Kyrgias, Georgios
    Theocharis, Stamatios
    JOURNAL OF BUON, 2019, 24 (03): : 883 - 888
  • [6] Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer
    Khinh Ranh Voong
    Feliciano, Josephine
    Becker, Daniel
    Levy, Benjamin
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (18)
  • [7] Targeting the PD-1/PD-L1 axis in non-small cell lung cancer
    Kumar, Rajiv
    Collins, Dearbhaile
    Dolly, Saoirse
    McDonald, Fiona
    O'Brien, Mary E. R.
    Yap, Timothy A.
    CURRENT PROBLEMS IN CANCER, 2017, 41 (02) : 111 - 124
  • [8] PD-L1 expression and its clinicopathologic and genomic correlation in the non-small cell lung carcinoma patients: An Indian perspective
    Jain, Ekta
    Sharma, Shivani
    Aggarwal, Aditi
    Bhardwaj, Nitin
    Dewan, Aditi
    Kumar, Abhishek
    Jain, Deepika
    Bhattacharya, Munmun
    Saurav, Gauraw Kumar
    Kini, Lata
    Mohanty, Sambit Kumar
    PATHOLOGY RESEARCH AND PRACTICE, 2021, 228
  • [9] Prognostic significance of PD-L1 in advanced non-small cell lung carcinoma
    Zhao, Yanjie
    Shi, Feng
    Zhou, Quan
    Li, Yuchen
    Wu, Jiangping
    Wang, Ruibin
    Song, Qingkun
    MEDICINE, 2020, 99 (45) : E23172
  • [10] PD-L1 heterogeneity in patients with non-small cell lung cancer
    Wei, Zhigang
    Fan, Linlin
    Yang, Xia
    Li, Jie
    Zhan, Xuemei
    Ye, Xin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (05) : E268 - E274
12345